- Researchers in Canada have published results of a small phase 3 clinical trial showing that minocycline, a relatively inexpensive oral antibiotic commonly used to treat acne, can reduce the likelihood that someone with clinically isolated syndrome (CIS) -- experiencing initial neurological symptoms suggestive of MS -- will go on to develop full-blown multiple sclerosis.
- Dr. Luanne Metz (University of Calgary) and colleagues across Canada tested minocycline against placebo in 142 people with CIS. After 6 months, those taking twice daily minocycline had a 28% reduced risk of developing definite…
Potrebbe interessarti anche
Agenzie del farmaco AISM Associazioni Blog Cannabis Cause CCSVI Cellule staminali definizione Diagnosi Dieta Diritto Disabilità Enti Estero Europa Eutanasia Farmaci Genetica Gravidanza inglese Istituzioni Microbioma News Omosessualità Ospedali Patologie Personaggi e Persone Ricerca Sintomi sociale Sport Vaccini